IP Library Granted Patent US 9,776,968
Granted Patent B2
US 9,776,968 · App. 15/073,591 · Granted Oct 3, 2017

Processes for producing cycloalkylcarboxamido-pyridine benzoic acids

Inventor: David Siesel (San Diego, CA)
Assignee: Vertex Pharmaceuticals Incorporated
C07D213/73C07D213/74C07D405/12
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,776,968
App. No.
15/073,591
Granted
Oct 3, 2017
Kind
B2
Abstract

The present invention relates to a process of providing the 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid in substantially free form (Compound 1).

Claims (39)

1. A process for preparing a compound of formula 6a:

wherein,

R is H, C 1-6 aliphatic, aryl, aralkyl, heteroaryl, cycloalkyl, or heterocycloalkyl;

R 1 is independently selected from —R J , —OR J , —N(R J ) 2 , —NO 2 , halogen, —CN, —C 1-4 haloalkyl, —C 1-4 haloalkoxy, —C(O)N(R J ) 2 , —NR J C(O)R J , —SOR J , —SO 2 R J , —SO 2 N(R J ) 2 , —NR J SO 2 R J , —COR J , —CO 2 R J , —NR J SO 2 N(R J ) 2 , —COCOR J ;

R J is hydrogen or C 1-6 aliphatic;

o is an integer from 0 to 3 inclusive; and

p is an integer from 0 to 5 inclusive;

comprising the steps of:

ib) providing compound 2a and compound 3a,

wherein,

R 1 is independently selected from —R J , —OR J , —N(R J ) 2 , —NO 2 , halogen, —CN, —C 1-4 haloalkyl, —C 1-4 haloalkoxy, —C(O)N(R J ) 2 , —NR J C(O)R J , —SOR J , —SO 2 R J , —SO 2 N(R J ) 2 , —NR J SO 2 R J , —COR J , —CO 2 R J , —NR J SO 2 N(R J ) 2 , —COCOR J ;

R J is hydrogen or C 1-6 aliphatic;

o is an integer from 0 to 4 inclusive; and

p is an integer from 0 to 5 inclusive;

iib) cross coupling compound 2a and compound 3a in a biphasic mixture comprising water, a first organic solvent, a first base, and a transition metal catalyst to produce compound 4a,

wherein, R 1 , o, and p are as defined for compounds 2a and 3a above;

iiib) oxidizing compound 4a to produce compound 5a,

wherein, R 1 , o, and p are as defined for compounds 2a and 3a above;

ivb) adding an amine group to the 6 position of the pyridyl moiety to produce compound 6a,

wherein,

R is H, C 1-6 aliphatic, aryl, aralkyl, heteroaryl, cycloalkyl, or heterocycloalkyl; and

R 1 , o, and p are as defined for compounds 2a and 3a above.

2. The process of claim 1 , wherein the first organic solvent is an aprotic solvent.

3. The process of claim 1 , wherein the first organic solvent is toluene.

4. The process of claim 1 , wherein the first organic solvent is a protic solvent.

5. The process of claim 1 , wherein the first base is an inorganic base.

6. The process of claim 1 , wherein the first base is potassium carbonate.

7. The process of claim 1 , wherein the transition-metal catalyst is a palladium-based catalyst.

8. The process of claim 1 , wherein the palladium-based catalyst is Pd(dppf)Cl 2 .

9. The process of claim 1 , wherein the cross coupling reaction is run at between 60° C. and 100° C.

10. The process of claim 1 , wherein the oxidation reaction is carried out using a peroxide.

11. The process of claim 1 , wherein the oxidation reaction is carried out using peracetic acid.

12. The process of claim 1 , wherein the oxidation reaction is carried out in the presence of an anhydride.

13. The process of claim 1 , wherein the oxidation reaction is carried out in the presence of phthalic anhydride.

14. The process of claim 1 , wherein the oxidation reaction is run at between 25° C. and 65° C.

15. The process of claim 1 , wherein the amination reaction is carried out in the presence of a sulfonyl compound.

16. The process of claim 1 , wherein the amination reaction is carried out in the presence of methanesulfonic anhydride.

17. The process of claim 1 , wherein the amination reagent used in the amination reaction is an alcohol amine.

18. The process of claim 1 , wherein the amination reagent used in the amination reaction is ethanolamine.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 4, 2017
From: MILLER, MARK THOMAS; MCCARTNEY, JASON; HADIDA RUAH, SARA SABINA; ZHOU, JINGLAN
To: VERTEX PHARMACEUTICALS INCORPORATED
Reel/Frame 043203/0136 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 20, 2017
From: SIESEL, DAVID
To: VERTEX PHARMACEUTICALS INCORPORATED
Reel/Frame 043055/0412 →
ASSIGNEE CHANGE OF ADDRESS Recorded Jul 20, 2017
From: VERTEX PHARMACEUTICALS INCORPORATED
To: VERTEX PHARMACEUTICALS INCORPORATED
Reel/Frame 043275/0192 →
Continuity (7)
Division 14061004 · Oct 23, 2013
Division 13351573 · Jan 17, 2012
Division 12327915 · Dec 4, 2008
Provisional Application 61109573 · Oct 30, 2008
Provisional Application 61012181 · Dec 7, 2007
Related Publication 20160200712A1 · Jul 14, 2016
Related Publication 20170158676A9 · Jun 8, 2017